Monthly Archives: June 2020

Kontrol Energy Closes First Tranche of Non-Brokered Private Placement for Proceeds of $1.25 Million

Acquisition Closing Date Set for July 6th, 2020

TORONTO, ON / ACCESSWIRE / June 24, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to announce that it has completed the first tranche closing of its previously announced (see press release dated May 19th, 2020) Non-Brokered Private Placement for Proceeds of $1.25 Million and has set July 6th, 2020 as the closing date for the previously announced acquisition of a building solutions company (the "Acquisition Target") (see press release dated May 19th, 2020).

"We look forward to completing this strategic acquisition since it is expected to grow our recurring revenues, add a number of new large cap real-estate owners and asset managers to our existing blue-chip customer base, and add 100 new buildings to Kontrol's customer base," said Paul Ghezzi, CEO of Kontrol Energy. "We expect more buildings to equate to increased operating leverage to scale recurring revenues through SaaS, IoT, Cloud and building automation. We have good visibility into closing the balance of our financing, and look forward to building upon our successful history of purchasing growing, accretive, and profitable companies"

Based on its July 31, 2019 fiscal year unaudited financial statements, The Acquisition Target generated $3.7 Million of revenue and $843,000 of Net Income before tax.

Approximately 40% of the Acquisition Target's revenues are expected to be annually recurring and the Acquisition Target has developed a scalable platform. In addition to operating synergies, Kontrol anticipates a significant opportunity for cross-sales through the merger of customers.

With the completion of the first tranche closing and existing cash on hand the Company has sufficient funding to complete the purchase of the Acquisition Target. The Company anticipates a second tranche closing of the Non-Brokered Private Placement by June 30, 2020.

The closing of the acquisition is subject to several conditions, including the provision of certain confirmatory due diligence information to Kontrol. For commercial reasons, the identity of the Acquisition Target will remain confidential until the completion of the acquisition.

About Kontrol Energy

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada's fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean's.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com or admin@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward Looking Statements:

Certain information included in this press release, including information relating to the completion of the purchase of the Acquisition Target, the closing of a second tranche of the private placement, future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute "forward-looking statements". Such forward-looking statements include, without limitation, statements regarding possible future acquisitions and/or investments in operating businesses and/or technologies, accelerated organic growth, expansion of smart energy technologies into US markets, strategic partnerships to expand into North American Markets, acceleration of recurring SaaS revenues, the provision of solutions to customers and Greenhouse Gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. Subsequent to year-end, there was a global outbreak of COVID-19 (coronavirus), which has had a significant impact on businesses through the restrictions put in place by the Canadian, provincial and municipal governments regarding travel, business operations and isolation/quarantine orders. At this time, it is unknown the extent of the impact the COVID-19 outbreak may have on the Company as this will depend on future developments that are highly uncertain and that cannot be predicted with confidence. These uncertainties arise from the inability to predict the ultimate geographic spread of the disease, and the duration of the outbreak, including the duration of travel restrictions, business closures or disruptions, and quarantine/isolation measures that are currently, or may be put, in place by Canada and other countries to fight the virus. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that the conditions, including confirmatory due diligence, related to the purchase of the Acquisition Target, will be fulfilled, that the balance of the private placement funds will be raised, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that the either the Acquisition Target or Kontrol will not fulfill conditions to the closing of the Acquisition; that the balance of the private placement funds will be raised, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

ReleaseID: 595045

Delta Legal Funding Teams Up with Infintech Designs to Build Website that Will Benefit Communities

MIAMI BEACH, FL / ACCESSWIRE / June 24, 2020 / Florida-based Delta Legal Funding and Infintech Designs – Web Design & SEO Company are pleased to announce their partnership to extend a professional helping hand to the community in the most efficient way possible.

The collaboration between the two companies was a result of extensive dialogue and hard work, driven by their desire to benefit community members. Specifically, both companies seek to show this support by helping clients or plaintiffs in need of pre-settlement funding, in a manner that is reliable, convenient, and accessible.

According to Delta Legal Funding, their ultimate goal is to offer a service that Americans can rely on during their time of need.

“The funds we secure for our clients range anywhere from $500 up to $100,000, depending on the specific details and circumstances of their case. We can process applications, approve and offer the money within 24 hours, guaranteeing that our clients can set things in motion and begin working on their case as soon as possible," a representative from the company said.

Moreover, the legal funding company assured that the requirements to apply for the pre-settlement funding program are minimal in nature, not requiring credit or an employment check from applicants. The company only gets paid if the client wins the case, protecting them against situations where they would fall into debt if they do not secure financial compensation.

Meanwhile, a representative from Infintech Designs, premier web design and SEO company said that when Delta Legal Funding reached out to them with a proposal to build and handle their website, they just couldn’t say no.

"Once they explained that this site would help members of the community receive the funding and support that they need, it was clear that we needed to work with them.”

Infintech added that while the site is still under construction, it will be a space that is easy to navigate and understand, containing all of the information a client may need to know about Delta Legal Funding’s partners and services. Aside from creating a functional and safe online platform, the website will utilize Search Engine Organization (SEO) in order to reach as many people as possible, helping them connect with a company that is ready to provide assistance during their time of need.

As an established name in the web design and SEO industry, Infintech stressed that in today’s digital and online world, a company’s website is responsible for roughly 83% of their new clients. This positions brands as an authority on the industry in question, encouraging visitors to take action and converting these increasing numbers into sales, leads, and phone calls.

Prospective clients anywhere in the United States can expect Delta Legal Funding's website running at full speed within the next few weeks. Through this site, the company promises to connect plaintiffs in need of pre-settlement funding to get ahead on their case. Unlike more traditional sources of cash advances or financial aid programs, this service comes with no hidden fees or other strings attached.

More details on Infintech Designs’ services can be found on its website. Interested parties may visit the site and fill out a contact form for inquiries. Additionally, both companies can be reached through their official social media pages.

For more information about Delta Legal Funding, contact the company here:

Delta Legal Funding
786-741-8003
Florida, USA

SOURCE: Delta Legal Funding

ReleaseID: 595096

Kyle Dendy Has Helped Over 7,000 People Start Their Speaking Career

DALLAS, TX / ACCESSWIRE / June 24, 2020 / All who are friends of Kyle Dendy know he has an entrepreneurial instinct he's never been able to shake. From shining shoes for $2 at age 7 to growing his online education company to 6 figures in only 6 months at age 22, people from all around the world are drawn to the young speaker from Dallas, TX.

Nationwide Speaking Tours

After he graduated from high school in 2016, Kyle began traveling the country speaking in schools, churches and organizations. Because this was all new to him, he had to learn the speaking industry as he went. From negotiating contracts and travel to calculating how many copies of his book to bring to an event, his title may have been "speaker," but he was exercising that entrepreneurial muscle mentioned earlier. As more opportunities came his way and he documented the journey on his Instagram and Facebook, countless people asked him how he was doing it. They wanted to know how they could land speaking gigs too.

At first, Kyle would just get on a phone call with them or offer some tips via direct messaging, but then he had an idea. In his words, "I was sitting in my room one day, and I had this idea to turn all I was being asked about into an online program people could access on demand. I decided on the name Speaker Secrets."

Starting from Scratch

In the 1.0 version of the program which launched in September 2019, Kyle sat in the kitchen and recorded his screen as he showed people the basics of landing speaking gigs. He showed them how to find decision makers and what they should say in order to land gigs at TEDx events, schools, etc. "Admittedly, the first version of the program was not that sharp," said Kyle. "The value was there, but the excellence wasn't where I wanted it to be. I threw it together because I didn't expect but a small amount of people to join, but as the program grew, it became evident that I needed to reshoot the content and make it phenomenal."

While in his hotel room in St. Louis on a TEDx speaking trip, he recreated every video to a standard of excellence he was proud of. Soon after, the course exploded. More than 7,000 people have paid to join the program from all around the world, and the results have been incredible. Especially when it comes to landing TEDx talks, Kyle's strategy and booking scripts have been blowing the minds of his students. Here's what some of them have been saying:

"In less than 2 hours, I got an invite to speak at a TEDx event."⁣
⁣
"I landed a TEDx talk within 4 hours of doing your course."⁣
⁣
"I landed 6 TEDx events in a matter of days. I actually booked the first one within hours of purchasing the course."⁣
⁣
"I booked a TEDx talk on the first day working with the speaker program."⁣

Automating the Process

Thinking like an entrepreneur, Kyle put systems in place to get students the best results with the least amount of friction. Even while he sleeps, students can see his ads on Instagram or Facebook, purchase the program and get results before Kyle even wakes up. In Kyle's words, "You can get started on your own, but you need systems if you want to scale. What may take hours of your day and half of your energy to do manually, a system or automation might be able to get the task done in an instant."

If you're interested in starting or growing a speaking career like Kyle's 7,000+ students, the Speaker Secrets course can help you do it. If you'd like to learn more about Kyle and what he does, you can visit him on Instagram, Facebook, or LinkedIn.

MEDIA CONTACT:
Kyle Dendy
Support@KyleDendy.com

SOURCE: Dendy Media

ReleaseID: 594919

Coronavirus (COVID-19) Impact on Anti-viral drugs Market Growth 2020, Global Demand, New Drug Development Pipeline, Top Companies, Industry Size, Share

Global Anti-viral drugs Market Information, by application (hepatitis, HIV/AIDS, herpes, influenza and others) and by mechanism of action (nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others) – Forecast to 2022

Pune, India – June 24, 2020 /MarketersMedia/ —

Anti-viral drugs Market Analysis

The global anti-viral drugs market is expected to exhibit a robust 6.9% CAGR over the forecast period from 2016 to 2022, according to the latest research report from Market Research Future (MRFR). The global anti-viral drugs market is mainly driven by the growing investment in healthcare channels, including research and development. The growing coronavirus pandemic has also been a major driver for the global anti-viral drugs market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2454

Viruses are life forms that inhabit a host and multiply in the host’s body, causing a wide range of diseases. Anti-viral drugs are drugs specifically made to counter specific viruses. The growing threat of viral diseases around the world has been the major driver for the global anti-viral drugs market. The increasing prevalence of coronavirus or COVID-19 has driven steady investment in the anti-viral drugs market in order to find effective cures for the disease. This is likely to remain a major driver for the global anti-viral drugs market over the coming months. Governments as well as private organizations around the world have come together around the world to find effective cures against coronavirus, as steady investment is needed in order to fund effective research into the development of effective cures for the disease. This is likely to drive the global anti-viral drugs market over the forecast period.

The growing prevalence of HIV-AIDS is also likely to be a major driver for the global anti-viral drugs market over the forecast period. Due to the absence of effective contraceptives, AIDS has become a major healthcare threat around the world, especially in developing countries in Africa and Latin America. This is likely to remain a major driver for the global anti-viral drugs market over the forecast period.

Impact of Covid-19 on the Anti-Viral Drugs Market

Corona Virus (Covid-19) has impacted every single industry, causing steep roads into the global economy. One such industry that has had both positive and negative impacts is the anti-viral drugs market. Coronavirus has negatively impacted by causing disruptions not only in the production of pharmaceuticals but also caused troubles in the supply chain. However positively it has impacted by showing great results in treating covid positive patients.

The concerns started aggravating by the fact that COVID-19 struck first, and worst, in China, which is the world’s one of the leading producers and exporters of active pharmaceutical ingredients (API) by volume. The majority of APIs for generic drug manufacturing across the globe are sourced from India, which also supplies approximately 30 percent of the generic APIs used in the US. However, Indian manufacturers rely heavily on APIs from China for the production of their formulations, procuring around 70 percent from China.

With an indefinite lockdown in China due to the deadly coronavirus outbreak, supplies of raw materials from China to produce drugs for treating HIV, cancer, epilepsy, malaria, and also commonly used antibiotics and vitamin pills, are also likely to be hit.

Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Anti-viral drugs Market and demographic challenges, showed how it could move forward in the coming years.

Anti-viral drugs Market Competitive Leaderboard:

Leading players in the global anti-viral drugs market include Cipla Inc., AstraZeneca AB, Novartis International AG, Abbott Laboratories, GSK plc, F. Hoffman-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., and Johnson & Johnson. Major players in the global anti-viral drugs market are likely to focus on research and development in the coming years in order to produce effective drugs for antiviral therapy. Coronavirus has also become a major target for players in the anti-viral drugs market, as the number of cases of coronavirus around the world is increasing at a steady rate.

Anti-viral drugs Market Segmentation:

The global anti-viral drugs market is segmented on the basis of application, mechanism of action, and region.

By application, the global anti-viral drugs market is segmented into hepatitis, HIV-AIDS, herpes, influenza, and others. Hepatitis and HIV-AIDS are likely to hold dominant shares in the global anti-viral drugs market over the forecast period. Hepatitis is a major concern in Africa, where the absence of capable healthcare channels and funding has resulted in a growing prevalence of the disease.

By mechanism of action, the global anti-viral drugs market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.

Anti-viral drugs Market Regional Analysis:

The Americas dominate the global anti-viral drugs market due to the strong presence of major healthcare industry players in North America, including the U.S. and Canada. The presence of leading market players in North America has resulted in a strong presence of research and development channels in the region, leading to a steady output of effective anti-viral drugs. North America is home to several large hospitals, which increases the prospects for drug makers, as strong distribution mechanisms are already in place in the region. The growing concern regarding COVID-19 in the region is also likely to be a major driver for the anti-viral drugs market in North America, as the U.S. has the leading number of COVID-19 patients in the world.

Europe has the second largest share in the global anti-viral drugs market and is likely to remain an important regional segment of the market due to the presence of several leading players in the market. Asia Pacific is expected to exhibit the highest growth rate in the global anti-viral drugs market over the forecast period.

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

…Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 06468459312
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/coronavirus-covid-19-impact-on-anti-viral-drugs-market-growth-2020-global-demand-new-drug-development-pipeline-top-companies-industry-size-share/88965360

Source: MarketersMedia

Release ID: 88965360

Covid-19 Impact Analysis: Clinical Trials Market size to Grow at 5.7% CAGR by 2023, Global Industry Growth, 2020 Trends

Clinical Trials Market Research Report: by Phase (Phase I, Phase II, Phase III) by Study Design (Interventional, Observational and Expanded Access), by Indication (Autoimmune/Inflammation) – Global Forecast Till 2023

Pune, India – June 24, 2020 /MarketersMedia/ —

Clinical Trials Market Analysis

The global clinical trials market is likely to grow at a 5.7% CAGR between 2017- 2023, according to the new report by Market Research Future (MRFR). The clinical trial, simply put, is a research study that includes people (patients or healthy volunteers) to test the efficacy & safety of a new medicine or treatment. In the healthcare industry, clinical trial is conducted for medical devices and medicine that includes surgical procedure and hearing aid.

Various factors are adding to the clinical trials market growth. According to the new MRFR report, such factors include the growth of new treatments like personalized medicine, high research and development spending of the pharmaceutical industry, and rising cases of diseases.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7787

On the contrary, lower healthcare reimbursement, especially in developing countries, strict regulations for patient enrolment, and lack of skilled workforce clinical research may limit the clinical trials market growth over the forecast period.

Clinical Trials Market Segmentation

The MRFR report gives an inclusive segmental analysis of the global clinical trials market report based on end users, indication, study design, and phase.

By phase, the global clinical trials market is segmented into phase IV, phase III, phase II, and phase. Of these, the phase III segment will lead the market over the forecast period.

By study design, the global clinical trials market is segmented into expanded access, observational, and interventional. Of these, the interventional segment will dominate the market over the forecast period.

By indication, the clinical trials market has been segmented into cardiovascular, obesity, diabetes, central nervous system (CNS) condition, oncology, pain management, and autoimmune/inflammation. Of these, the oncology segment will have a major share in the market over the forecast period.

By end user, the global clinical trials market is segmented into research institutes, dental academic, dental institutes, and dental hospitals & clinics.

Clinical Trials Market Regional Analysis

By region, the clinical trials market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period. Increasing prevalence of diabetes, cancer, and other life-threatening diseases, innovations in product development, huge patient population, and the presence of multiple pharmaceutical companies are adding to the clinical trials market growth in the region.

The clinical trials market in Europe is predicted to have the second-largest share over the forecast period. Growing demand for new products across the region, new favorable regulations for clinical trials, rising cases of disease & new disease cases, and high research & development spending of the pharmaceutical industry are adding to the clinical trials market growth in the region.

The global clinical trials market in the APAC region is predicted to grow at a fast pace over the forecast period. Increasing support from the government to develop outsourcing hubs, increasing focus to develop medication for rare diseases, and rising prevalence of diseases are adding to the clinical trials market growth in the region. Besides, the developing economy in China and Australia and low operating costs are also adding market growth.

The global clinical trials market in the MEA is predicted to have the smallest share over the forecast period for the small number of clinical trials centers, in the African region, lack of scientific knowledge, less technical facilities, and poor economies. The market in the Middle East will have a higher market share for the immense healthcare expenditure coupled with the presence of a well-established healthcare sector in Qatar, Kuwait, and Saudi Arabia.

Clinical Trials Market Key Players

Eminent players profiled in the global clinical trials market report include Pfizer, Laboratory Corporation of America, Clinipace, Novo Nordisk A/S, Eli Lilly and Company, SGS SA, ICON plc, Quintiles IMS, Paraxel International Corporation, and Charles River Laboratories.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

…TOC Continued

LIST OF TABLES

Table 1 Global Clinical Trials Synopsis, 2017 – 2023

Table 2 Global Clinical Trials Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Clinical Trials Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Clinical Trials Market By Phase, 2017 – 2023, (USD Million)

Table 5 Global Clinical Trials Market By Study Design, 2017 – 2023, (USD Million)

Table 6 Global Clinical Trials Market By Indication, 2017 – 2023, (USD Million)

….Continued

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Clinical Trials Market

Figure 3 Segmentation Market Dynamics For Global Clinical Trials Market

Figure 4 Global Clinical Trials Market Share, By Phase, 2016

Figure 5 Global Clinical Trials Market Share, By Study Design, 2016

Figure 6 Global Clinical Trials Market Share, By Indication, 2016

…Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/clinical-trials-market-7787

About Market Research Future:

Source URL: https://marketersmedia.com/covid-19-impact-analysis-clinical-trials-market-size-to-grow-at-57-cagr-by-2023-global-industry-growth-2020-trends/88965371

Source: MarketersMedia

Release ID: 88965371

COVID-19 Drives Gene Expression Analysis Market 2020, Global Industry Research Report Size, Share, SWOT Analysis, Growth, Top Company Revenue

Gene Expression Analysis Market Research Report: Information by Product (Consumables & Instruments), Service (Gene Expression Profiling), Application (Drug Discovery & Others)- Forecast till 2023

Pune, India – June 24, 2020 /MarketersMedia/ —

Gene Expression Analysis Market Overview

As per Market Research Future (MRFR) analysis, the global gene expression analysis market is estimated to hold a market value of USD 3.250 million with a CAGR 9.1% from 2018 to 2023 (forecast period).

Gene expression analysis is a research focused on functional genomics that broadens the scope of the study of genes and gene transcripts. Synthesizing functional gene products like functional RNAs and protein species provides insights into how an intact organism survives when a particular gene is missing.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7805

Gene Expression Analysis Market Dynamics

Personalized medicine is becoming more popular, with an increasing number of genetic disorders. In addition, increasing awareness of personalized medicine is expected to drive growth over the forecast period. As per the data published by Foley & Lardner LLP, the Food and Drug Administration (FDA) approved 16 new personalized medicinal products in 2017. Moreover, the advancement of genomic databases increased government support for genomics, and growth in personalized medicine is likely to drive the market.

However, the shortage of skilled labor and the high cost of instruments may inhibit market growth during the forecast period.

Gene Expression Analysis Market Segmentation

The global market for gene expression analysis has been segmented into product, consumables, instruments, services, application, and end-user.

Based on the product, the global market for gene expression analysis has been segmented into consumables and instruments.

Based on consumables, the global market for gene expression analysis has been further segmented into reagents and DNA chips.

Based on instruments, the global market for gene expression analysis has been further segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and others.

Based on services, the global market for gene expression analysis segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.

Based on the application, the global market for gene expression analysis has been segmented into drug discovery, diagnosis, research, and others.

Based on end-user, the global market for gene expression analysis has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others.

Gene Expression Analysis Market Regional Analysis

Regionally, the global gene expression analysis market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas are predicted to dominate the global market for gene expression analysis due to increasing research activities and the increasing popularity of gene expression tests. In addition, the well-developed healthcare sector is predicted to improve the American market for gene expression analysis.

Europe is predicted to hold the second-largest position in the global market for gene expression analysis. Market growth in this region is due to the availability of research funding.

The Asia Pacific is projected to be the fastest-growing region on the market due to rising investment by governments in genomics and continuously developing economies. As stated in the report published by the International Journal of Social and Developmental Concerns in October 2017, the growth of public primary and secondary care facilities in Malaysia has decreased over the last few years and has not kept pace with modern urbanization. These factors, therefore, restrict the growth of the market in this region.

The Middle East and Africa are estimated to have the least market share.

Gene Expression Analysis Market Key Players

Some of the significant participants in the global gene expression analysis market are GENERAL ELECTRIC COMPANY, Illumina, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Pacific Biosciences of California, Inc., Oxford Gene Technology, BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, Genotypic Technology Pvt Ltd, Danaher, Macrogen Inc.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Equipment Trends & Assessment

Chapter 5. Market Factor Analysis

…TOC Continued

LIST OF TABLES

Table 1 Global Gene Expression Analysis Market Synopsis, 2018–2023

Table 2 Global Gene Expression Analysis Market Estimates And Forecast, 2018–2023 (USD Million)

Table 3 Global Gene Expression Analysis Market, By Region, 2018–2023 (USD Million)

Table 4 Global Gene Expression Analysis Market, By Product, 2018–2023 (USD Million)

Table 5 Global Gene Expression Analysis Market, By Services, 2018–2023 (USD Million)

Table 6 Global Gene Expression Analysis Market, By Applications, 2018–2023 (USD Million)

….Continued

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure For Global Gene Expression Analysis Market

Figure 3 Market Dynamics For Global Gene Expression Analysis Market

Figure 4 Global Gene Expression Analysis Market Share, By Product, 2017

Figure 5 Global Gene Expression Analysis Market Share, By Services, 2017

Figure 6 Global Gene Expression Analysis Market Share, By Applications, 2017

….Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gene-expression-analysis-market-7805

About Market Research Future:

Source URL: https://marketersmedia.com/covid-19-drives-gene-expression-analysis-market-2020-global-industry-research-report-size-share-swot-analysis-growth-top-company-revenue/88965375

Source: MarketersMedia

Release ID: 88965375

Coronavirus Business Impact: Enteral Feeding Devices Market 2020, Industry Size by Product, Application, Technology Trends, SWOT Analysis, Top Company

Enteral Feeding Devices Market Research Report: Information by Product (Enteral Feeding Tubes, Enteral Feeding Pumps, Enteral Syringes, Administration Sets, Consumables), – Forecast till 2023

Pune, India – June 24, 2020 /MarketersMedia/ —

Enteral Feeding Devices Market Overview

As per Market Research Future (MRFR) analysis, the global enteral feeding devices market held a valuation of USD 2,302.4 million in 2017. It is estimated to grow at a CAGR of 6.1% from 2017 to 2023 (forecast period).

Enteral feeding is a nutritional therapy process where nutrients are supplied directly to the gastrointestinal tract (GIT). It is a therapy for patients who are unable to get sufficient nutrition by eating or drinking or unable to swallow food by mouth. Enteral feeding devices help deliver medications and nutrients directly to the stomach, duodenum, or jejunum via either the nose, mouth or direct percutaneous route.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7828

Enteral Feeding Devices Market Dynamics

Market growth drivers include a rising geriatric population worldwide, along with a rising prevalence of chronic diseases, an increasing change from parenteral to enteral nutrition, and a growing incidence of preterm births. For example, the World Health Organization (WHO) stated that the global elderly population was 841.0 million in 2013, 962.3 million in 2017, and expected to reach more than 2.0 billion by 2050.

On the other hand, complications associated with enteral feeding devices, including inadvertent dislodgement of tubes and strict refund policies, are expected to hinder market growth over the forecast period.

Enteral Feeding Devices Market Segmentation

The global market for enteral feeding devices market has been segmented into product, age group, indication, and end-user.

Based on the product, the global market for enteral feeding devices has been segmented into enteral feeding pumps, enteral feeding tubes, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further segmented into nasoenteric feeding tubes, oroenteric feeding tubes, and enterostomy feeding tubes. The segment for enterostomy feeding tubes is additionally divided into gastrostomy tubes, gastrojejunostomy tubes, and jejunostomy tubes. The nasoenteric feeding tubes segment is further categorized into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The segment of enteral pumps is expected to lead the market over the forecast period due to the low risk of complications with the use of feed pumps, improved portable pump designs, and the growing use of pumps in hospitals and home care settings.

Based on the age group, the global market for enteral feeding devices has been divided into adults and pediatrics.

Based on indication, the global market for enteral feeding devices has been segmented into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further divided into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end-user, the global enteral feeding devices market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Enteral Feeding Devices Market Regional Analysis

Region-wise, the global enteral feeding devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas led the global market for enteral feed devices in 2017. This is due to the involvement of significant market players and well-established healthcare infrastructure, the growing prevalence of lifestyle diseases, and rising technical advancements in enteral feeding. Such market players are engaged in manufacturing technologically advanced devices, including texture modifications in products that meet individual patient requirements. The demand for disposable and portable pumps from healthcare centers and small peripheral laboratories is on the rise, thus encouraging market development.

Europe is anticipated to follow Americas in terms of value owing to early product approval, market launch, and high adoption of enteral feeding pumps, as well as an increasing number of reconstructive surgeries and radiotherapy procedures in the United Kingdom, Germany, and France.

The Asian Pacific market is likely to have a comparatively higher CAGR during the forecast period due to an increasing geriatric population, an expanding number of malnutrition patients and preterm births, and a growing awareness for the use of enteral feed devices. For example, the WHO estimated that there were approximately 1.71 million preterm births in China and 3.5 million preterm births in India between January 2014 and November 2015.

The market for enteral feed devices in the Middle East and Africa is expected to witness moderate market growth rate between 2018 and 2023 due to the development of the healthcare sector in the Gulf Cooperation Council (GCC) countries.

Enteral Feeding Devices Market Key players

Some of the spearheads in the global enteral feeding devices market are Abbott Laboratories, Medtronic plc, Cook Medical, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Boston Scientific Corporation, CONMED Corporation, Moog, Inc., Nestlé, Halyard Health, Inc., and Vygon SA.

Table Of Contents:

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

…Continued

LIST OF TABLES

Table 1 Global Enteral Feeding Devices Market Synopsis, 2018–2023

Table 2 Global Enteral Feeding Devices Market Estimates And Forecast, 2018–2023 (USD Million)

Table 3 Global Enteral Feeding Devices Market, By Region, 2018–2023 (USD Million)

Table 4 Global Enteral Feeding Devices Market, By Product, 2018–2023 (USD Million)

Table 5 Global Enteral Feeding Devices Market, By Age Group, 2018–2023 (USD Million)

Table 6 Global Enteral Feeding Devices Market, By Indication, 2018–2023 (USD Million)

…Continued

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Enteral Feeding Devices Market

Figure 3 Segmentation Market Dynamics For Global Enteral Feeding Devices Market

Figure 4 Global Enteral Feeding Devices Market Share, By Product, 2017

Figure 5 Global Enteral Feeding Devices Market Share, By Age Group, 2017

Figure 6 Global Enteral Feeding Devices Market Share, By Indication, 2017

…Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828

About Market Research Future:

Source URL: https://marketersmedia.com/coronavirus-business-impact-enteral-feeding-devices-market-2020-industry-size-by-product-application-technology-trends-swot-analysis-top-company/88965377

Source: MarketersMedia

Release ID: 88965377

Covid-19 Outbreak Impact on Molecular Diagnostics Market Size 2020, Global Industry Analysis, Growth Rate, Applications, Top Company Profiles

Molecular Diagnostics Market Research Report: Information by Product (Reagents & Kits, Instruments and Services & Software), by Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray ), by Application (Infectious Diseases, Oncology, Genetic Tests)

Pune, India – June 24, 2020 /MarketersMedia/ —

Molecular Diagnostics Market Insight

Molecular diagnostic techniques are used to analyze biological markers in the genome and proteome. These tests help in diagnosing diseases, their root cause, and determining therapies to be administered in the treatment. The molecular diagnostic market has been witnessing an enormous growth over the past few years. The growth attributes to the rising demand for improved diagnostic procedures to control the prevalence of myriads of chronic diseases and infectious disease growing at an alarming rate.

Besides, increasing awareness regarding the benefits of these techniques and technological advancements are boosting the market growth, increasing the uptake of molecular diagnostic methods. According to Market Research Future (MRFR), the global molecular diagnostics market is estimated to reach USD 16,319.09 MN by 2025, registering 8.57% CAGR during the assessment period (2019-2025). Rise in incidences of different types of cancer and increasing cancer researches are the major growth propellers of the market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/1171

Recent COVID 19 outbreak has impacted the global molecular diagnostics industry phenomenally. Countries with high rates of coronavirus testing, such as China, Germany, and South Korea, are leading the pack in getting molecular-based testing ready for the market. Diagnostic technology companies are increasingly teaming with electrochemistry, molecular biology, and microfluidics for the development of hand-held portable devices that can leverage molecular diagnostics for this infectious disease – COVID 19.

Additionally, many diagnostic companies are focusing on the development of connected, portable lab to provide on-site care, including molecular diagnostic tests. They are making substantial investments targeting the development of a portable point-of-care COVID-19 test. On the other hand, stringent regulatory policies are significant factors projected to pose challenges in the growth of the market. Nevertheless, increasing emphasis on diagnostic companies would support the market growth during the estimated period.

Impact of COVID-19 on the Global Molecular Diagnostics Market

The spread of COVID-19 worldwide has dramatically increased the number of suspected cases and the geographic areas where laboratory testing must be implemented and intensified. The molecular testing for COVID-19 has led to shortages of molecular testing reagents worldwide for COVID-19. Beyond supply issues, there are limitations of absorption capacity in several regions, especially in low- and middle-income countries.

Currently Available Testing Kits: Molecular assays and immunoassays are the most widely adopted diagnostics tests for COVID-19. Furthermore, digital solutions are being developed to monitor and track the development of COVID-19. For instance, InferRead CT Pneumonia is being developed by Beijing-based Infervision Technology, which detects lesions from symptoms of pneumonia. Breath biomarkers that can detect and track the virus are currently being developed.

Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Molecular Diagnostics Market and demographic challenges, showed how it could move forward in the coming years.

Global Molecular Diagnostics Market – Segments

The report is segmented into five dynamics;

By Product: Reagents & Kits, Instruments, Services & Software, and others.

By Technique: Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray, and others.

By Application: Infectious Diseases, Oncology, Genetic Tests, and others.

By End User: Hospitals & Clinics, Diagnostic Laboratories, and others.

By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.

Molecular Diagnostics Market – Regional Analysis

North America leads the global molecular diagnostics market. The largest market share attributes to the rising prevalence of chronic diseases and growing demand for innovative diagnostics in the region. Also, the presence of key industry players and increasing numbers of pharmaceutical and biotechnology companies in the region boost market growth. The availability of advanced healthcare facilities and high per capita healthcare expenses in the region impact the growth of the market phenomenally. The North American molecular diagnostics market is estimated to retain its dominance over the global market throughout the forecast period.

Europe stands second in the global molecular diagnostics market. The market is majorly driven by the availability of R&D funds and rising support from the government for the development of the life science sector. Besides, the increasing geriatric population, alongside the growing occurrences of chronic diseases in the region, creates a huge demand for effective diagnosis procedures. The European molecular diagnostics market is projected to create a substantial revenue pocket during the review period.

The Asia Pacific molecular diagnostics market has emerged as a rapidly growing market globally. Factors such as the large population base and growing biotechnology companies in the region push the growth of the market. Also, the burgeoning pharmaceutical industry in the region supports market growth exponentially.

China, Japan, and India dominate the Asia Pacific market owing to the growing economy and manufacturing activities in the molecular diagnostic field. Moreover, the rapidly growing medical devices sector in these countries provides further impetus to the regional market growth. The APAC molecular diagnostics market is expected to grow at a significant CAGR during the forecast period.

Global Molecular Diagnostics Market – Competitive Landscape

Highly competitive, the molecular diagnostics market appears fragmented due to the presence of many large and small players. Industry players are facing extreme pricing pressures, especially in the low-end market. Companies in the high-end market are pursuing collaboration and partnerships with other players to innovate new products.

Molecular Diagnostics Market Major Players:

Players leading the global molecular diagnostics market include Hologic, Inc., F.Hoffmann-La Roche Ltd., QIAGEN, Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Thermo Fisher Scientific, Siemens, and Agilent Technologies, among others.

Molecular Diagnostics Industry/ Innovation/ Related News:

May 19, 2020 —- Bosch Healthcare Solutions (Germany) and BioGX (the US), announced their partnership for point of care molecular tests to expand molecular diagnostic tests offering for the Vivalytic platform. This partnership would accelerate the planned expansion of the test portfolio for the Vivalytic all-in-one platform.

Bosch Healthcare Solutions offers innovative diagnostic solutions in the healthcare and medical technology sectors. BioGX develops innovative molecular reagents for DNA-/RNA-based tests and provides partner-specified formulation and manufacturing services for molecular reagents platforms.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171

About Market Research Future:

Source URL: https://marketersmedia.com/covid-19-outbreak-impact-on-molecular-diagnostics-market-size-2020-global-industry-analysis-growth-rate-applications-top-company-profiles/88965381

Source: MarketersMedia

Release ID: 88965381

His Secrets to Success: FxLifestyle Shares his Personal Rags to Riches Story

The founder of the renowned FxLifestyle.com platform reveals his fascinating journey from abject poverty to an enviable lifestyle.

June 24, 2020 —

London, UK – Samir Tahir, aka FxLifestyle certainly lives the lifestyle. At the age of 23, he is living the kind of life that most people only dream about. Travelling the world, staying in the best 5-star resorts and the owner of more than a few super cars, FxLifestyle enjoys his freedom, and is also happy to provide for his family. But despite appearances, the luxurious lifestyle is not something that he takes for granted. Only a few short years ago, FxLifestyle was living in abject poverty, wondering where his next meal was coming from.

Growing up in one of the poorest neighbourhoods in the city, FxLifestyle always felt conspicuous as the poorest kid in his class. His parents struggled to make ends meet, but were constantly fighting about money.

“Those were desperate times for my family,” says FxLifestyle. “There were no jobs to be had; no hope for the future. I dropped out of school at a young age with no idea of what I was going to do with my life.”

All of which is in stark contrast to the life that he and his family lead today.

With a huge following on social media of over 300,000 people, FxLifestyle is now a Forex trader with his own platform from which he sends trades that his members can copy and profit from. He also offers courses that teach people how to trade Forex ‘like a pro’ and profit.

“Basically I’m showing people how to buy and sell currency online from their phones or laptops. It’s something that can be done from anywhere in the world as long as you have Wi-Fi or a connection. Forex is not hard and can be mastered fairly quickly.”

FxLifestyle first discovered Forex when he was about 15 years old during his school lessons.

“I was stumbling around on Google looking for ways to make money. As usual, I was absolutely broke; I had no money to my name. I just wanted to find some sort of an income. But the more I looked, the more I found out about Forex. I saw that a lot of young people my age were making millions. And these were people like me with no education.”

FxLifestyle was intrigued. And it wasn’t long before he was hooked. He started selling food on lunch breaks and used the little profit he made to invest in Forex. What started off as $50 to $100 grew into over $100,000 over the next couple of years, and that $100,000 profit then turned into millions.

“It started off small, but there was no looking back. At this point, I’ve not only made my own fortune, I’m now helping other people make their fortunes, too!”

On a mission to see his students achieve the same success as himself, FxLifestyle says that on average many of his members make up to $2,500 or more per week.

“The one thing I learned is that you do not need to be rich to make money. You can start off poor just like I did. But if you work at it, you can end up living your dream lifestyle too!”

For more information, visit the website at www.fxlifestyle.com.

Contact Info:
Name: Samir T
Email: Send Email
Organization: FxLifestyle.com
Phone: 07449191773
Website: http://www.fxlifestyle.com

Video URL: https://www.youtube.com/watch?v=6Jat9ipBo5Q&t%20

Release ID: 88965195

Openly Closes $15M in Series A Fundraising Round to Execute a Multi-State Expansion

Premium Homeowners Insurer Expands Its Coverage to Empower Agents

BOSTON, MA / ACCESSWIRE / June 24, 2020 / Openly, the premium homeowners insurance platform, today announced that it has closed a $15 million Series A investment. The round was led by Obvious Ventures, with participation from existing investors including Gradient Ventures (Google's AI-focused Venture Fund), Point Judith Capital (PJC) Ventures, and others.

Since launching in late 2019, Openly has seen rapid adoption of its home insurance product and has expanded its coverage, currently on track to be live in 10 or more states by year-end. The round will be used to enter new states, including Massachusetts, Indiana, Ohio, Georgia, and South Carolina. Agents are already live on its platform in Arizona, Illinois, Pennsylvania, Tennessee, and Kentucky.

Founded by insurance industry and technology veterans Ty Harris and Matt Wielbut, Openly uses its technology to simplify the homeowners insurance process for independent agents and consumers, enabling them to obtain quotes in under 15 seconds. Openly's product combines cutting edge technology with sophisticated pricing methodology to offer homeowners more comprehensive coverage and protection at a competitive price. By streamlining traditionally inefficient and manual processes, Openly frees up agents to spend more time doing what independent agents do best; provide expertise and customized coverage options. For Homeowners, Openly's product provides more coverage and is easier to understand at a competitive price.

"We founded Openly to bring transparency to the insurance industry that has been traditionally opaque," said Ty Harris, CEO and Co-Founder of Openly. "Closing the Series A is a validation of the demand from agents and homeowners and is a testament to the team's tireless efforts to provide our customers with choice and a competitive product. We look forward to taking our offering nationwide and providing more consumers with comprehensive coverage at a really competitive price-especially at a time of financial uncertainty when consumers are understandably looking to reduce costs without sacrificing their protection against risk."

Vishal Vasishth, Co-Founder and Managing Director of Obvious Ventures, adds, "Openly is bringing technology-driven transparency to an industry known for being opaque, inefficient and manual. This represents a positive transformation and independent agents alike."

"Openly brings great experience and optimized insurance for everyone in the ecosystem: the consumer, the agent, and the reinsurer," said Zach Bratun-Glennon, Partner at Gradient Ventures. "The demand for this insurance among agents and consumers is a testament to the tech-forward product that Openly has built, and I think this team is just getting started."

About Openly

Openly is a Boston-based premium homeowners insurance company. Its centralized platform offers comprehensive coverage using advanced pricing models. Founded by industry veterans in 2017, Openly is dedicated to delivering modern and transparent homeowners insurance and empowering independent agents across America. For more information, visit Openly.com or linkedin.com/openlyinc.

About Obvious Ventures

Obvious Ventures is a venture capital firm investing in entrepreneurs reimagining the global economy. Since launching in 2014, Obvious has backed over 50 purpose-led companies using technology to create a smarter, healthier, more sustainable world. Obvious was co-founded by Ev Williams, James Joaquin, and Vishal Vasishth, with Andrew Beebe and Nan Li now also serving as Managing Directors. More information is available at www.obvious.com.

About Gradient Ventures

Gradient Ventures is Google's AI-focused venture fund – investing in and connecting early-stage startups with Google's resources, innovation, and technical leadership in artificial intelligence. The fund focuses on helping founders navigate the challenges in developing new technology products, allowing companies to take advantage of the latest techniques so that great ideas can come to life. Gradient was founded in 2017 and is based in Palo Alto, California. For more information, visit www.gradient.com.

About PJC

PJC is an early-stage venture capital firm focused on investing in, supporting, and building relationships with entrepreneurs who are creating the future. The firm has invested in over 90 companies which have generated a total of 16.5 billion in equity value. Notable portfolio companies include Expensify, Nest, GetWell Network, Health-e Commerce, Nexamp, and Yandex. PJC was founded in 2001 and is based in Boston, MA. For more information, visit http://pjc.vc.

Contact:

Jamie Kemp
jamie@calibercorporateadvisers.com
(516) 417-3975

SOURCE: Openly

ReleaseID: 594972